The medical device firm reported a Q2 GAAP loss of $0.91 per share, narrower than forecasts, while revenue fell short by $0.43M.
SeaStar Medical Holding reported a Q2 GAAP loss of $0.91 per share, beating expectations by $0.06. The result reflects a smaller deficit than anticipated but underscores ongoing financial challenges.
Revenue for the quarter totaled $0.06M, missing estimates by $0.43M and declining 82.4% year-over-year. Cost of goods sold rose to $54 thousand from $27 thousand in the comparable 2025 period, impacting gross margins.
The company did not disclose immediate market reaction to the earnings release.